Hint mode is switched on Switch off

Twist Bioscience Corporation, ordinary share
TWST, US90184D1000

Add a stock to WL
Choose all Reset all
Twist Bioscience Corporation, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company’s DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, ...
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company’s DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company was founded in 2013 and is headquartered in San Francisco, California.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Twist Bioscience Corporation
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TWST
  • Placement
    31.10.2018
  • Lock up period
    180
  • Number of papers
    5,000,000
  • Volume of raised funds
    70 mln USD
  • Placement share
    18.79%
  • Final placement price
    14 USD
  • Price change since placement date
    512.86%
  • By capitalization
    372.54 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TWST
  • Placement
    09.05.2019
  • Lock up period
    180
  • Number of papers
    3,750,000
  • Volume of raised funds
    78.75 mln USD
  • Placement share
    11.8%
  • Final placement price
    21 USD
  • Price change since placement date
    308.57%
  • By capitalization
    667.26 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TWST
  • Placement
    21.02.2020
  • Lock up period
    180
  • Number of papers
    4,642,857
  • Volume of raised funds
    130 mln USD
  • Placement share
    12.25%
  • Final placement price
    28 USD
  • Price change since placement date
    206.43%
  • By capitalization
    1,061.3 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TWST
  • Placement
    05.06.2020
  • Lock up period
    180
  • Number of papers
    3,030,303
  • Volume of raised funds
    100 mln USD
  • Placement share
    6.89%
  • Final placement price
    33 USD
  • Price change since placement date
    160%
  • By capitalization
    1,452.02 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
IV q eng
Show all Hide

Related Stock indices

Indicators

News

11/06/2026 Analyst Initiates Coverage on Twist Bioscience (NASDAQ:TWST) with 'Overweight' Rating
04/05/2026 Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results
21/04/2026 Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026
11/02/2026 Twist Bioscience Corporation: Unregistered Sales Of Equity Securities, Other Events, Financial Statements And Exhibits
05/02/2026 Twist Bioscience Corporation: Submission Of Matters To A Vote Of Security Holders
All organization news

Holders

Industry Leaders

Registration is required to get access.